Markets 

Australia investigates possible link of blood clot case to AstraZeneca vaccine

FILE PHOTO: A Palestinian health worker prepares AstraZeneca vaccine against the coronavirus disease (COVID-19) during a vaccination drive in Tubas, in the Israeli-occupied West Bank March 25, 2021. Picture taken March 25, 2021. REUTERS/Raneen Sawafta

MELBOURNE (Reuters) – Australia is investigating whether a blood clotting disorder case recorded on Friday is related to the AstraZeneca coronavirus vaccine, Deputy Chief Medical Officer Professor Michael Kidd said.

Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the vaccine.

“Investigators have not at this time confirmed a causal link with the COVID-19 AstraZeneca vaccine, but investigations are ongoing,” Kidd told a televised briefing.

He added that more details are expected to be known on Saturday.

Australia’s Therapeutic Goods Administration (TGA), the medicine and therapeutic regulatory agency, has said previously that AstraZeneca vaccine was not associated with an increase in the overall risk of blood clots.

Source: Read Full Article

You May Also Like

VW might have to cut production further due to chip shortage

Compass Minerals jumps on finding 2.4 million metric tons of lithium resource

European stocks log best winning streak since 2006, fourth week of gains